A prospective, monocentric, observational randomised controlled pilot study of two all-in-one multicomponent
Valentina Dini1, Antonella Vietina1, Alessandra Michelucci1
1Department of Dermatology, University of Pisa, Pisa, Italy.
Journal of wound care
|January 13, 2026
まとめ
Two compression bandage systems for phlebological diseases demonstrated effective therapeutic pressures and good tolerance in healthy volunteers. Further studies in patients with venous leg ulcers are recommended for real-world validation.
科学分野:
- 静脈学
- 生物医学工学
- 皮膚科学
背景:
- 静脈疾患には効果的な圧迫療法が必要です。
- 多成分圧迫システムは、静脈障害の管理に有望なソリューションを提供します。
- 新しい圧迫システムの性能と許容性の評価は非常に重要です。
研究 の 目的:
- 2つのオールインワン多成分圧迫システムの包帯下の安静時および作業時圧力性能を評価すること。
- これらのシステムの静的剛性指数と装着中の許容性を健常ボランティアで1週間評価すること。
- 調査デバイス(InD)と対照デバイス(CoD)の性能と耐容性を比較すること。
主な方法:
- 7日間にわたる包帯下の圧力を測定するために空気圧センサーが使用されました。
- 包帯のずれを測定し、参加者は快適さと耐容性を評価しました。
- 調査者は、パディングと皮膚保護を評価しました。
主要な成果:
- 両システムとも、初日の後には治療範囲内(20〜40mmHg)の平均安静時および作業時圧力を達成しました。
- 両デバイスとも、3日目までに平均包帯ずれは5cm未満でした。
- 両方の包帯は良好な耐性があり、InDはCoDよりも有意に掻痒感が少なかったです。
- 両システムとも、高い装着感と満足のいく足首の可動性が報告されました。
結論:
- 評価された両方の圧迫包帯システムは、治療的な作業圧と許容できる安静時圧を達成しました。
- 両システムは、健常ボランティアにおいて良好な全体的な耐容性と装着感を示しました。
- 臨床現場における静脈性潰瘍患者のより大きなコホートにおけるさらなる検証が推奨されます。
関連する概念動画
Bioavailability Study Design: Healthy Subjects Versus Patients
143
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
143
Bioavailability Study Design: Single Versus Multiple Dose Studies
200
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
200
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
308
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
308
Bioequivalence studies: Biowaivers
218
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
218
Acute Coronary Syndrome III: Diagnostic Studies
207
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
207
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K


